Pharmacophore-Based Identification and Molecular Characterization of Potent Neprilysin Inhibitors: Biochemical and Therapeutic Implications for Cardiovascular Diseases.

Kuo CT, Wu YC, Li JM, Ju TC, Tseng TS

Open source

DOI
10.1111/cbdd.70247
Published
2026 Feb
Container
Chemical biology & drug design
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/cbdd.70247,
  title = {Pharmacophore-Based Identification and Molecular Characterization of Potent Neprilysin Inhibitors: Biochemical and Therapeutic Implications for Cardiovascular Diseases.},
  author = {Kuo CT and Wu YC and Li JM and Ju TC and Tseng TS},
  year = {2026},
  journal = {Chemical biology \& drug design},
  doi = {10.1111/cbdd.70247},
  url = {https://doi.org/10.1111/cbdd.70247}
}

RIS

TY  - JOUR
TI  - Pharmacophore-Based Identification and Molecular Characterization of Potent Neprilysin Inhibitors: Biochemical and Therapeutic Implications for Cardiovascular Diseases.
AU  - Kuo CT
AU  - Wu YC
AU  - Li JM
AU  - Ju TC
AU  - Tseng TS
PY  - 2026
JO  - Chemical biology & drug design
DO  - 10.1111/cbdd.70247
UR  - https://doi.org/10.1111/cbdd.70247
ER  - 

APA

CT, K., YC, W., JM, L., TC, J., & TS, T. (2026). Pharmacophore-Based Identification and Molecular Characterization of Potent Neprilysin Inhibitors: Biochemical and Therapeutic Implications for Cardiovascular Diseases.. Chemical biology & drug design. https://doi.org/10.1111/cbdd.70247

Source records